LBI-HTA - Publications - Search - Subject: QV 701-737 Pharmacy
Number of items at this level: 18.

Fischer, S. and Zechmeister-Koss, I. (2014): Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoidal diseases. HTA-Projektbericht 79.

Fried, A. (2007): [The pharmaceutical industry puts pressure on publishers]. HTA-Newsletter 53: 1.

Mad, P. and Geiger-Gritsch, S. and Mittermayr, T. and Wild, C. (2009): Tocolysis in preterm labour - A systematic review of evidence-based guidelines, effectiveness and health economic evaluations. HTA-Projektbericht 030.

Mantsch, S. and Petersen, P. and Wild, C. (2016): Pharma: Disclosure of transfers of value in austria 2015. Rapid Assessment 007d.

Petersen, P. and Wild, C. (2017): Sponsoring of Patientinitiatives in Austria 2015. Update of the Systematic Analysis 2014.. Rapid Assessment 007b_1. Update 2017.

Wild, C. (2007): [Biosimilars]. HTA-Newsletter 54: 2.

Wild, C. (2006): [Generics vs. brand name drugs after patent expiration] . ÖKZ: Österreichische Krankenhauszeitung 47 (10): 16.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics]. ITA-Newsletter September 2004: 13.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics. Editorial]. HTA-Newsletter 28: 1.

Wild, C. (2004): [Transparency in the pharmaceutical industry. Editorial]. HTA-Newsletter 25: 1-2.

Wild, C. (2003): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter December 2003: 9.

Wild, C. (2002): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter September 2002: 11.

Wild, C. (2002): [Guidelines for manufacturers and medical associations on submission of evidence. Editorial]. HTA-Newsletter 08: 1.

Wild, C. (2001): [Project on generics: Saving 5 million schilling]. ITA-Newsletter December 2001: 10.

Wild, C. (2001): [Innovations and (expensive) followers]. ITA-Newsletter December 2001: 9.

Wild, C. (2001): [Generics and cost reduction: A project in Austria]. HTA-Newsletter 02: 4.

Wild, C. (2001): [Approval of innovative drugs]. ORF ON Science.

Wild, C. and Khan, A. and Erdos, J. (2015): Sponsoring of Patient Initiatives in Austria. Systematic Analysis. Rapid Assessment 007b.

This list was generated on Sun Aug 20 06:00:24 2017 CEST.